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Vukomanović, M.; Kurtjak, M.;
Masciotti, V.; dal Zilio, S.; Greco, S.;
Lazzarino, M.; Krušić, V.; Perčić, M.;
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Abstract: Extracellular vesicles (EVs) are nanometric membranous structures secreted from almost
every cell and present in biofluids. Because EV composition reflects the state of its parental tissue,
EVs possess an enormous diagnostic/prognostic potential to reveal pathophysiological conditions.
However, a prerequisite for such usage of EVs is their detailed characterisation, including visuali-
sation which is mainly achieved by atomic force microscopy (AFM) and electron microscopy (EM).
Here we summarise the EV preparation protocols for AFM and EM bringing out the main challenges
in the imaging of EVs, both in their natural environment as biofluid constituents and in a saline
solution after EV isolation. In addition, we discuss approaches for EV imaging and identify the
potential benefits and disadvantages when different AFM and EM methods are applied, including
numerous factors that influence the morphological characterisation, standardisation, or formation
of artefacts. We also demonstrate the effects of some of these factors by using cerebrospinal fluid
as an example of human biofluid with a simpler composition. Here presented comparison of ap-
proaches to EV imaging should help to estimate the current state in morphology research of EVs
from human biofluids and to identify the most efficient pathways towards the standardisation of
sample preparation and microscopy modes.
Keywords: extracellular vesicles; human biofluids; nanotechnology; atomic force microscopy;
electron microscopy; morphology
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1. Introduction
Advanced and optimised microscopy methods are required to visualise and charac-
terise morphology of extracellular vesicles (EVs), a heterogenous groups of nanoparticles
(NPs) secreted by cells and regarded as highly promising source of diagnostic, prognostic,
and therapeutic tools [1,2]. Both the choice and performance of microscopy method on one
side and EV form on the other side, including whether a biofluid or a purified sample is
used as an EV source, can significantly impact visualisation of EVs. Thus, we first provide
description of general properties of EVs followed by an overview of EV isolation methods.
Next, we describe imaging options for different electron and atomic force microscopy
modes and describe the main challenges of these methods when imaging EVs present in
cerebrospinal fluid (CSF) or isolated by size-exclusion chromatography (SEC). We also
discuss some general aspects of sample preparation protocols, but also point to certain
specificities depending on the applied microscopy mode. Moreover, sources of variation
and the formation of artefacts are discussed. The critical evaluation of the published reports
and terminology used for describing the shape, structure, morphology, and topography
will help to estimate the current state in the morphology research of EVs from biofluids,
especially from CSF, and identify the most efficient pathways for selecting, implementing,
and standardising specific microscopic technologies.
2. Extracellular Vesicles: General Properties
EVs are nanosized phospholipid membranous structures ubiquitously found in bioflu-
ids, secreted from almost every cell, and thus reflect both physiological and pathophysio-
logical changes of their parental cells. The lipid membrane of an EV contains proteins (e.g.,
tetraspanins, receptors and other molecules) and diverse luminal content with bioactive
cargo that includes nucleic acids (DNA, mRNA, miRNA and lncRNA), proteins, organelles,
or infectious particles [1,3]. The size distribution of EVs is between 50 and 200 nm and they
possess a negative zeta potential. However, there can be variations in size, composition,
and function, which in general complicate EV isolation, detection and enumeration [1,4].
EVs are classified into several subgroups based on their biogenesis or release pathway,
among which exosomes have been the most widely investigated [5]. Exosomes are typically
in the size of around 30–150 nm, luminal cargo is comprised of proteins, DNA, RNA,
peptides and lipid derivatives surrounded by a lipid membrane. They are formed in
the endocytic pathway through inward budding of endosomal membranes during their
maturation into multivesicular endosomes and secreted by the fusion of multivesicular
bodies with the plasma membrane. Their internalisation by recipient cells can occur
through various mechanisms including endocytosis, micropinocytosis, phagocytosis, and
plasma membrane fusion where its contents can influence cellular processes. They are
detected on the basis of protein markers of the endosomal biogenesis pathway such as
CD9, CD63, CD81 and others [6–8]. However, proteomic studies have demonstrated
heterogeneity in this protein cargo, indicating the existence of many subclassifications of
exosomes, which makes their definitive identification difficult. Exosomes released from
different cells in different environments also have different membrane proteins and lipid
compositions [9]. To further augment the complexity and heterogeneity of EVs, exomeres,
sub-50 nm non-membranous particles have been recently discovered [1,10,11].
EVs are available as biomarker sources from biofluids such as urine, blood (serum and
plasma), saliva, cerebrospinal, amniotic and other biofluids, which makes liquid biopsy
an option for EV-based diagnostics [12]. Since the viscosity, fat and protein content of
these fluids vary considerably, EV isolation protocol needs to be adjusted to the biofluid of
interest. Additional factors that affect the amount, purity and content of EVs are diseases,
use of medications, age, gender, general lifestyle, dietary habits, but also sample collection,
handling and storage [1,13]. In comparison with other biofluids, CSF does not contain high
concentration of NPs. NTA revealed 108 of NPs per millilitre in native CSF [14], while
1012 per millilitre in plasma [15]. The concentration and composition of EVs in biofluids of
healthy subjects may differ from the ones in patients suffering from a particular disease.
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Depending on the state of the disease, their cargo can contain different information about
the disease [16,17]. EVs from the CSF are implicated in diverse physiological and patho-
physiological processes of the brain [5]. As part of normal brain functions, they can be
involved in: (i) angiogenesis, inflammation, morphogen transportation, programmed cell
death, redox homeostasis and immunological functions, gene regulation, neurogenesis [18];
(ii) intercellular communication, and communication in general [19], since they can cross
the blood-brain barrier (BBB) and transfer signal to other neuronal cells [2]; (iii) nerve
regeneration, synaptic function, plasticity, epigenetic regulation [8,14]. Additionally, EVs
can report neurological conditions and brain diseases including Huntington’s disease,
Alzheimer’s disease, multiple sclerosis, Parkinson’s disease and several mental disorders,
such as depression, schizophrenia, anxiety, and bipolar disorder treatment response. The
activated monocytes release EVs that can influence BBB. A leaky BBB is associated with neu-
roinflammation, schizophrenia, bipolar disorder, and major depressive disorder [2,8,20,21].
EVs contribute or respond to pathogenic mechanisms, disease settings and progression,
with cancer being the most prominent [22]. EVs serve as biomarkers to define tumours, they
have pro-metastatic potential [16]. However, not all cancer cells might be using EVs to grow
and metastasise, and thus not all tumours will reveal their presence by increased number
of tumour-specific EVs since recent and more sophisticated methods for EV quantification,
including flow cytometry and luciferase-based in vitro assays, show that certain cancer
cells release lower amounts of exosomes [23–25]. As sources of non-invasive diagnostic
biomarkers, EVs could help clinicians utilise mental health biomarkers and determine
candidates for treatment strategies [26]. Furthermore, EVs can carry bioactive cargo and
are thus used as therapeutic vehicles to deliver drugs or nucleic content [5,8].
3. Overview of EV Isolation Methods
So far, there is no gold standard for the isolation and determination of physical and
biochemical characteristics of various EV populations. The isolation method is selected
according to the type of the sample and the downstream analysis. Well-isolated EVs
can prevent their misinterpretation and confusion with other entities of similar size (like
viruses and proteins) that can also be present in complex biofluid systems. Currently, the
available methods for EV isolation include ultracentrifugation (UC), ultrafiltration (UF),
SEC, polymer-based precipitation and recently immunoaffinity-based precipitation [27,28].
To date, UC-based methods remain the most commonly used for EV isolation and
purification. Differential UC consists of multiple centrifugation steps, which provide sepa-
ration of EVs from other non-EV particles based on particle size and density. Differential
UC is often followed by density gradient UC to provide additional separation of EVs from
other similarly sized particles according to their bouyon density in the solution of either
sucrose, iohexol, or iodixanol [27]. Although UC provides an effective way of isolating EVs,
high centrifugal forces can lead to significant losses due to disruption of EV membranes,
as well as a fusion of EV membranes, particle clustering and agglomeration along with
the background noise [27,29,30]. Such fusion events can lead to the formation of mislead-
ing artefacts, including large heterogenous EV aggregates and multi-layered vesicles not
present in the native samples [29,31]. Emelyanov et al. [32] reported EVs isolated by UC
with a sizes even larger than 400 nm.
UF is another frequently used technique, both as a stand-alone or as a supplemental
method for EV isolation. It is based on the separation of EVs from non-EV components in
relation to their size by sieving the sample through membranes with different molecular
weight cut-off (MWCO) values, using centrifugation, pressure or vacuum [27,28]. Even
though UF can provide an efficient way of concentrating EVs in the sample, the applied
pressure needed for the passage of particles through MWCO filter can lead to deformations
and membrane ruptures. In addition, UF can cause significant losses of material as well
as contamination due to the binding of EVs to the membrane and clogging of the filter
pores [28,33].
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Precipitation-based isolation methods have gained much popularity due to their rela-
tively low cost and overall simplicity of the procedure. In recent years, many commercial
precipitation-based EV isolation kits have become available, such as ExoQuickTM (Sys-
tem Biosciences, Palo Alto, CA, USA), PureExoTM (Qiagen, Hilden, Germany), ExoPrep
(HansaBioMed, Tallinn, Estonia) and Total Exosome Isolation kit (Invitrogen, Waltham,
MA, USA), which employ superhydrophillic polymers for EV precipitation [27,34]. Other
precipitation protocols utilise chemicals like sodium acetate or protamine, or polymers such
as polyethylene glycol to induce the precipitation of EVs. Alternatively, protein organic
solvent precipitation (PROSPR) has been proposed as a method of purifying EVs by precip-
itation of soluble proteins present in the sample [27,35]. Although these methods provide a
high EV yield, the common disadvantages include high protein contamination, resulting in
overall low purity of the isolated vesicles, whilst the use of organic solvents can invoke the
formation of artificially produced multilayered vesicles [36]. Moreover, retention of the
polymer used for the EV isolation in the sample can interfere with further analyses and EV
visualisation, e.g., Serrano-Pertierra et al. [37] reported transmission electron microscope
(TEM) analysis to be unfeasible for ExoQuick EV samples due to the precipitating agent
interference with the electron beam [38].
In contrast to other methods which rely on the separation of EVs from other particles
based on their size, density and solubility, immunoaffinity capture offers a highly specific
mode of isolation by employing antibodies against EV surface proteins [27,28]. This
approach could provide isolation of EVs with high selectivity and purity, but is still not
preferred due to several limiting factors. Although numerous proteins have already been
associated with EVs, a protein of interest has to be expressed on the surface of EVs to be
suitable for immunoaffinity capture, which narrows down the pool of potential protein
candidates for this method [33]. Secondly, the presence of markers for immunoisolation
in the overall EV population is often varying, which can lead to a loss of EVs that do
not express the chosen protein [38]. Moreover, the detachment of EVs from the capture
antibodies should also be addressed, because the elution buffers used for this process can
irreversibly damage the EV membranes and cause their loss of function [28,38].
Although initially intended for the separation of peptides from amino acids, SEC has
been successfully adapted for EV isolation [28]. SEC enables the separation of particles
according to their hydrodynamic radius by passing the sample through a porous stationary
phase. The stationary phase allows smaller particles such as proteins to enter the pores
and traverse a longer path until elution, while the particles that are too big to access the
pores travel faster and elute right after the void volume of the column [28,39]. The most
apparent limitation regarding the SEC isolation of EVs is its inability to separate EVs from
other particles of similar size, including lipoproteins and chylomicrons [39,40]. However,
SEC does not seem to compromise the integrity and functionality of isolated EVs like
other commonly used EV isolation methods [28,36,41,42]. SEC dilutes the sample which
represents a great problem when isolating EVs from the cell culture in vitro due to the
initially low NPs concentration. On the other hand, biofluids contain higher concentrations
of NPs comparing to cell culture samples and dilution is not a limiting factor for them.
Thus, SEC seems an ideal method for the isolation of high-quality EVs from such samples,
which is necessary for investigating their biological functions.
After the isolation, a quantitative assessment (size, size distribution and concentra-
tion) is evaluated by commonly explored methods, including light scattering, tunable
resistive pulse sensing (TRPS), diffraction measurement of Brownian motion (NTA), which
have been reviewed elsewhere [3,43]. Detailed characterisation of size and morphology
is required before any downstream investigations, e.g., functional tests, investigations of
intercellular signalling pathways or clinical translation of EVs-based research [5]. To recog-
nise and thoroughly characterise EVs in a heterogeneous sample, it is important to study
individual EVs [44]. Therefore, electron microscopy (EM) and atomic force microscopy
(AFM) are employed to identify and characterise individual EVs from biofluids [17,45].
Both AFM and EM are low-throughput techniques, since they allow only several particles
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to be observed at a time, and they give detailed information on the size, shape and defor-
mation morphology of EVs, but in AFM also biomechanical and biophysical characteristics
like adhesion, stiffness, density or elastic properties can be obtained [46,47]. The results
of particle counting and size distribution should be compared with microscopy results to
investigate populations that are imaged and to verify the effects of the isolation methods
on morphology [43,48].
4. Electron Microscopy
The size of many EVs from the biofluids is below the resolution of even the most
enhanced optical microscopes. Therefore, EM is employed to assess their morphology. In
general, there are two types of electron microscope: scanning electron microscope (SEM)
and TEM. Both operate by irradiating the sample with a beam of electrons under a high
vacuum (10−4–10−5 Pa) and rely on the interactions of these electrons with the atoms of the
sample to create an image. Thus, both microscopes consist of three main components: (i) an
electron gun, which produces an electron beam, (ii) magnetic lenses (ML) and apertures
(A) in metal diaphragms for shaping the electron beam and guiding it to the sample (S) or
a detector, and (iii) detectors, which collect the signals resulting from the interactions of the
electron beam with the sample and convert them to an image or a graph (Figure 1).
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Figure 1. Electron microscopy. Schematic represe tation of scanning electron microscope (SEM and STEM—with additional
detectors installed below the sample to detect the trans i ted electrons; (a) and trans ission electron icroscope (TEM;
(b). : aperture, L: agnetic lens, S: sa ple.
The various interactions with the sample cause the electrons from the beam to change
their trajectory, their energy and/or their wave properties. This phenomenon is called
scattering and forward scattered electrons due to Coulomb interactions with the sample
atoms are the basis of the contrast in a TEM image [49], whereas backscattered electrons
(BSEs) are often used for creating high-contrast images in the SEM [50,51]. Moreover, the
electron beam can excite or even eject electrons from the sample. This gives signals such as
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secondary electrons, X-rays or Auger electrons [49–51]. Electron-generated X-rays from
the sample can be detected in SEM as well as TEM and enable a local analysis of chemical
composition (energy-dispersive X-ray spectroscopy, EDXS) based on characteristic X-ray
emission spectra of the elements.
4.1. Scanning Electron Microscopy
In SEM, the electrons are accelerated in the gun with voltages from a few hundred
volts to 30 kV and the electron beam is focused (converged) into a probe that moves along
the surface of the sample by a scanning system—scanning coils [50,51]. The detectors,
which are positioned above the sample, obtain a signal from each spot during the scanning
and convert the intensity of each pixel into an image (Figure 1a). For biological samples,
like EVs, the secondary electron (SE) detectors are the most relevant [52]. They detect
low-energy electrons that are ejected only from close to the surface of the sample and can
provide valuable information about the sample (morphology and composition, texture of
the surface and roughness) [50]. Hence, SEM gives information about EV surface properties,
including size, shape and morphology. In some specific cases, BSE detector could also be
useful, particularly with heavy-metal labelled surfaces [53]. It collects electrons that come
from the greater depths under the sample surface than SEs and give information about the
composition and topography [54].
4.2. Transmission Electron Microscopy
For TEM, the electrons are accelerated in the gun with voltages from 80 to 400 kV
(or higher), the beam is almost parallel, and the sample needs to be thin enough (usually
<100 nm, depending on the voltage and the sample), so that electrons can penetrate through
it and reach the detector (Figure 1b). During their journey through the sample, the electrons
scatter to different angles from the primary (incident) beam axis. Denser and thicker parts
of the sample scatter more, likewise the parts consisting of heavier elements with a larger
atomic number of the nucleus (Z) [49,55]. In this way, the so-called mass-thickness or
Z-contrast is created, which is the predominant type of contrast for a biological specimen.
Imaging can then be conducted in two ways. In the more common one, electrons up
to a certain chosen angle are selected so the parts of the specimen, at which they were
scattered more, appear darker, whereas the parts, where the electrons were scattered less,
appear brighter. This type of imaging is called bright-field (BF). On the other hand, if the
scattered electrons are selected instead so-called dark-field (DF) image is obtained [49].
The resolution is higher in a TEM than in a SEM. If lens imperfections (aberrations) are
corrected, it can be brought down to atomic level (<1 Å). But even in a less advanced TEM,
a resolution of 1 nm can regularly be achieved [49].
TEM is the most common type of electron microscopies for EV imaging [20], where it
is mainly used for monitoring the quality and purity of EV-containing samples because
it can better than other methods discriminate single EVs from similarly sized non-EV
particles [56,57]. The specific recognition of EVs can be further enhanced by attaching
immunolabels, e.g., electron opaque Au NP (with diameters ranging from 1 to 20 nm)
functionalised with a specific antibody, to the antigen sites on the EVs [58]. This results in
the so-called immuno-TEM imaging, which enables studying the structure functionally
and observing the position of specific proteins [59]. The main disadvantage of using
immunolabelling with conventional TEM is that the sample can be greatly altered during
the required preparation procedure to make it immobilised and dried. On the other
hand, instead of drying, biological samples can be fully solidified by freezing at very low
temperatures during imaging (77 K). In that way, EVs can be observed hydrated even at
high vacuum. This EM technique is called cryo-TEM, a powerful tool for assessing the
morphology of EVs. It preserves the native structure of biological material and avoids
alterations or modifications, commonly encountered in conventionally used EM techniques.
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4.3. Scanning Transmission Electron Microscopy
If additional detectors are installed in SEM below the sample to detect the electrons
transmitted through it, BF and DF scanning transmission electron microscope (STEM)
images can be created (Figure 1a). The main advantages of STEM over SEM are a higher
resolution (down to <0.3 nm in the aberration-corrected instruments with field emission
guns) and contrast, as well as the additional valuable information from the forward
scattered electrons [60]. Hence, in case a TEM is not available, STEM can be used to
ensure a more detailed analysis of EV morphology. Conventional TEM generally provides
better resolution than a comparable STEM, but even in comparison with TEM (especially
the ones without aberration corrections) STEM can exhibit a few beneficial properties:
higher contrast, less noise in DF images and less influence by the lens aberrations [49].
Moreover, Au NP used in immunostaining can be distinguished more easily from other
high-mass parts in a DF STEM image than in a TEM image [61]. Figure 2 presents examples
of EV-like structures in native CSF and EVs isolated from CSF by SEC, as visualised
by different EM methods under different conditions. EVs isolated by SEC from CSF
were detected by protein markers of the endosomal biogenesis pathway CD9 and CD81,
Supplementary Figure S1.
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Figure 2. Electron microscopy of EV-like nanoparticles in native CSF (a) and EVs isolated by SEC (b), imaged in different
modes. (A): sample fixed with PFA, on Si-wafer, air dried, tilted stage at 45◦, SE; (B): sample fixed with GA, on polycarbonate
membrane, air dried, SE; (C): sample fixed with GA, on polycarbonate membrane, dehydrated in ethanol gradient and
critical point dried, SE; (D): sample fixed with GA, on carbon-formvar grid, uranyl acetate contrasted, air dried, STEM-BF;
(E): sample fixed with GA, on carbon-formvar grid, Uranyless contrasted, air dried, STEM-BF; (F): sample fixed with
GA, on c rbon-formvar grid, UA-zero contrasted, air dried, STEM-BF; (G): sample fixed wit PFA, on Si-wafer, air dried,
tilted stage at 45◦, SE; (H): sample fixed with GA, on polycarbonate membrane, dehydrated in ethanol gradient and
critical point dried, SE; (I): sample fixed with PFA, on carbon-formvar grid, uranyl acetate contrasted, air dried, STEM-DF;
(J): sample fixed with PFA, on carbon-formvar grid, uranyl acetate contrasted, air dried, STEM-BF; (K): sample fixed with
PFA, on carbon-formvar grid, uranyl acetate contrasted, air dried, TEM-BF at 120 kV; (L): sample fixed with GA, on lacey
carbon grid, dehydrated in ethanol gradient and critical point dried, TEM-BF at 200 kV. (A,G,I,J): Supra Zeiss 40 (Carl
Zeiss AG, Oberkochen, Germany); (B–F): JSM 7800F (JEOL Ltd., Tokyo, Japan); (H): JSM 7600F (JEOL); (K): JEM 1200
EXII (JEOL); (L): JEM 2100 (JEOL). EV: extracellular vesicle, CSF: cerebrospinal fluid, SEC: size-exclusion chromatography,
PFA: paraformaldehyde, GA: glutaraldehyde, SE: scanning electron microscope—secondary electron detector, STEM-DF:
scanning electron microscope—dark field detector, STEM-BF: scanning electron microscope—bright field detector, TEM-BF:
transmission electron microscope—bright field detector. Scale bars represent 50 nm length in all images.
Several properties of EVs complicate EM investigation of their morphology and
decrease the reliability of the obtained results. Electron microscopes are conventionally
designed for observation of dry solid samples under high vacuum, whereas EVs are in the
form of buffer suspensions after their isolation from the biofluids [62]. Moreover, EVs are
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non-conductive, consist of light atoms and can get easily damaged by heating. For these
reasons, a special preparation procedure is necessary for observation of EVs in an electron
microscope. The preparation protocol should be well selected and well optimised to keep
their structural and topological characteristics as close as possible to their native form [63].
4.4. Sample Preparation
4.4.1. Adsorption of EVs on a Substrate
The first step in preparing EVs for an EM analysis is their deposition onto a substrate.
For SEM, a silicon wafer or different membrane filters are usually utilised. Silicon wafer
conducts electrons and prevents charging, which enables better resolution [20]. By contrast,
membrane filters are non-conductive and require sputtering with metals or carbon prior to
sample observation [64].
For TEM analysis, EVs are captured on a supporting metal grid covered by a thin
amorphous film/membrane that has to be electron transparent, unsusceptible to beam
damage and withstand the weight of the sample [58,65]. Several types are generally encoun-
tered: (i) continuous polymer membrane, (ii) continuous carbon film and (iii) perforated
(holey) polymer membrane. Continuous polymer membranes are most often made of
either collodion (nitrocellulose), Formvar (polyvinyl formal) or Triafol (butyryl cellulose
acetate) [65]. They are usually covered by a 5–10 nm carbon layer for reinforcement and
better flow of electrons. However, this also makes them hydrophobic and impairs the
capturing of the samples from the aqueous media. Therefore, electrical discharge under
low pressure (glow discharge) is often used to enhance EV adhesion [66]. Perforated (holey)
polymer membranes are pierced with small holes that are reinforced by sputtering with
carbon. Such films must be used for high-resolution TEM (HR-TEM) microscopy and
for cryo-TEM. The holes provide a cleaner background without any texture. The sample
rests on the edge of the hole and is observed in the hole as if it was floating freely in the
microscope [58].
4.4.2. Fixation
The goal of fixation is to preserve a native form of biological sample and prevent its
response to alternation of environment and conditions. There are two distinct types of
fixation: (i) chemical fixation (required for SEM and conventional TEM) and (ii) cryofixation
(required for cryo-TEM).
In order to protect biological samples from osmotic damage, fixatives are added into
the buffer [65]. These chemicals react with the biomolecules that constitute the sample
to inactivate them, cross-link them and make them less soluble, but retain the shape and
structure of their connections [58,67]. Selecting the buffer during the process is critical. It
should be as close as possible to the native sample environment. Nevertheless, possible
interactions of the buffer with fixation and staining agents must be checked to minimise the
appearance of artefacts [68]. Sometimes this cannot be easily prevented, e.g., when using
SEC for EV isolation, the required mobile phase is salt buffer, which can form crystals of
similar size as EVs (Figure 3A). Three different fixatives are currently mostly in use: (i) OsO4,
(ii) formaldehyde (methylene glycol), and (iii) glutaraldehyde (GA) [69]. OsO4 is a strong
oxidant that reacts especially with C=C double bonds of lipids, whereas aldehyde fixatives
mainly react with amino groups and other nucleophilic groups (e.g., thiols) of polypeptide
chains [67,70]. With its very fast and efficient cross-linking, glutaraldehyde is the best
choice for the fixation of EVs. In addition, with its favourable cross-linking of membranes
and introduction of a heavy metal, which obviates an additional staining step, OsO4
post-fixation after GA also seems a very good option, especially for the TEM analysis of
EVs [70]. Nevertheless, extremely toxic OsO4 is much more difficult to handle than GA and
over-fixation as a result of excessive crosslinking can also lead to conformational changes
in membrane macromolecules, including changes in tertiary and quaternary structure of
proteins [71]. The main purpose of fixation is to protect the sample against osmotic damage
and additionally against the extraction of internal biomolecules, denaturation or autolysis
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(destruction of a cell by its own enzyme). Yet, it does not protect against the structural
damage due to high surface tension during evaporation of water. Therefore, to preserve the
structure, fixation has to be followed by a proper dehydration step rather than air-drying.
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Immunolabelling is frequently interfering with the chemical fixation, especially with
GA, which leaves many free aldehyde groups in the sample and significantly limits the
accessibility to antigens [72]. This issue can be mitigated by using special antibodies that
recognise glutaraldehyde linked amino acids [70], neutralising the aldehyde groups by
soaking in a phosphate–glycine buffer [58], or in a blocking buffer (containing bovine
serum albumin) [73], or by performing the fixation after immunolabelling.
For cryo-TEM observations, the cryofixation is the necessary prerequisite. This proce-
dure involves very fast freezing (quenching/vitrification) of a suspension of EVs. It has to
be fast enough to keep the ice crystals sufficiently small (<10 nm), so that they do not dam-
age the structure of the sample. This can be achieved by cooling the sample to below 145 K
at a rate of at least 103–104 K/s [58,74]. The most efficient coolant is liquid ethane [75,76],
which has also been the most frequently used cryogen for cryofixation of EVs from the
biofluids [29,31,32,35,36,77–80]. Cryofixation preserves the natural (realistic) structure of
the sample much better than chemical fixation and it avoids or reduces the extraction or
displacement of small molecules, ions and other labile or diffusible substances [58,67].
Even a combined chemical fixation never completely preserves the structure. It does not
conserve saturated lipids or sugars and loosely bound ions and other very small molecules
can get lost as well. Moreover, chemical fixation changes the distribution of molecules
within the structure by binding together parts that were not originally bound and it adds a
non-negligible number of atoms and molecules from the fixative into the structure [58].
4.4.3. Dehydration
Dehydration is the final step in the biological sample preparation for conventional
EM (SEM or TEM). It is a process of water removal from the sample in a way that avoids
structural damage. Simple water evaporation (drying in air) is not possible, because water
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has a very high surface tension (around 0.07 N/m), which destroys the structure even if it
is immobilised by fixation [67]. A fact that has generally been neglected even in the more
recent TEM studies of EVs [81,82], in which they were simply air-dried after fixation and
a characteristic “cup shape” was observed [83,84]. There are many other options besides
evaporation to remove water from the sample, which can preserve its structure much better
and have been used for biological sample preparation for decades. Therefore, for all EM
investigations of EVs from the biofluids, the following dehydration procedures are highly
recommended: (i) solvent exchange, (ii) chemical dehydration, (iii) critical point drying, or
(iv) freeze-drying.
For chemically fixed samples, dehydration is most frequently done by gradually
replacing the water in the sample with a solvent with lower surface tension, such as
ethanol, acetone and diethyl ether [58,65,67,85]. Apart from a long solvent exchange
process, water can also be chemically converted to methanol and acetone by a fast reaction
with 2,2-dimethoxypropane (DMP) at pH below 6 [67,86]. Since the removal of these
solvents by evaporation still does not preserve the morphology well, they should be further
exchanged with some water-immiscible liquids such as tetramethylsilane (Me4C, TMS)
or hexamethyldisilazane (Me3-Si-NH-Si-Me3, HMDS) [85,87–91]. An even better option
is to exchange them with CO2 at supercritical conditions (above 31 ◦C and 7,3 ·106 Pa),
for which the surface tension vanishes [67,92]. It is important to point out that fixation is
required for all these dehydration methods by solvent exchange, to protect biomolecules
from coagulation, denaturation or dissolution by alcohol and other organic solvents [58].
For samples that were fixed by cryofixation and are intended for conventional (dry sample)
EM, the vitreous ice can be removed by sublimation [65,74].
Immunocryo-TEM combines cryo-TEM techniques with immunogold labelling over-
coming drawbacks and artefacts arising from chemical fixation and preserving EV structure
and shape. Antigens can get denatured in many steps of the sample preparation for TEM so
a lot of antigenicity is lost even if labelling is performed before fixation [58]. For this reason,
cryo-fixation and freeze-drying, which preserve the immunoreactivity much better, are
recommended in combination with immunolabelling [67]. Immunocryo-TEM has the major
advantage of providing a way to identify the source cell of EVs and to immunophenotype
EVs and their subpopulations in their natural hydrated environment.
4.4.4. Staining
As biological samples consist of light elements (C, H, N, O, P, S) with low Z values,
they create very low contrast in TEM. Therefore, microscopists traditionally try to increase
the Z value of the biological samples by staining them with atoms with high Z values.
There are two types of staining: negative and positive.
Negative staining denotes that there is no chemical reaction between the dye (contrast
agent) and the sample, but the dye (typically a salt of heavy metal) is only adsorbed on the
support film and the sample surface, so it can be easily removed by washing. It is a very fast
and simple method, in which TEM grid with undried sample suspension is turned over onto
a droplet of the dye solution (with the concentration of 0.5–2%) and removed after 20–30 s
to prevent a chemical reaction of the contrast agent with the sample [58]. Many different
contrast agents can be used: uranyl acetate (UA) (UO2(CH3COO)2), phosphotungstic
acid (24WO3·2H3PO4), sodium silicotungstate (Na4Si(W3O10)4), methylamine tungstate
(CH3NH2WO3), UA-Zero (YbCl3 and phosphotungstic acid), Uranyless (gadolinium and
dysprosium salts), ammonium molybdate ((NH4)6Mo7O24), aurothioglucose, etc. [58].
Even though UA is becoming unattainable due to its radioactivity, it remains the preferred
contrast agent for the negative staining. Due to its simplicity and usefulness for the
determination of sizes and shapes of viruses, negative staining has been very popular in
TEM analyses of EVs as well. Nevertheless, it can bring also many artefacts, such as size
and shape changes, uneven staining, precipitation of dye crystals (Figure 3A), decreased
resolution, possible mistaking grid membrane holes for sample particles etc [58,66]. It is
sometimes used in immuno-TEM as well, to better see the edge of the biological sample
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underneath [58]. However, this can also add to the confusion, as heavy metal contrast
agent precipitates can be mistaken for Au NP, especially in a BF image [61]. In this case,
EDXS can be useful to help resolve the chemical nature of the dark circles (Figure 3E).
Positive staining is used when there is a chemical reaction between the contrast agent
and certain parts of the biological sample, which consequently appear darker in a BF image.
One such contrast agent, OsO4, has already been explained in detail in Section 4.4.2. A
similar oxidant dye is also RuO4. Then some chemicals that are used for negative staining,
namely phosphotungstic acid and UA, can also generate positive staining, if the sample
is exposed to them for a longer time (several minutes to several hours) and/or if they are
applied in higher concentrations or dissolved in other solvents than water [58]. Another
very popular chemical for positive staining is lead citrate, which is produced by a reaction
between lead nitrate and sodium citrate in an aqueous solution at a pH of around 12 [58].
The disadvantage of this agent is that pH has to stay above 10 during the reaction to
prevent precipitation, so it has to be conducted in a sealed vessel protected from CO2 and
containing NaOH. UA delivers good contrasting results of membranes, nucleic acids and
nucleic acids containing protein complexes [93]. Moreover, it appears that lead and uranyl
ions can attach to the sites already containing osmium [58]. The artefacts of this method
are mainly associated with the formation of electron-dense precipitates that cover parts of
the sample and can also be mistaken for biological sample particles or inorganic NP used
for immunolabelling [58,61] (Figure 3E). Uranyl precipitates are usually needle-shaped,
while lead precipitates are spherical [58].
4.4.5. Coating
Biological samples require coating with a conductive material in order to prevent
charging, i.e., electron accumulation on a non-conductive biological surface. This is usually
achieved by sputtering the surface with a few nanometres (2–10 nm) [20] of metals (Au,
Cr, Pt or Pd) or carbon [60]. Without coating, charging leads to image distortion (which
can result in misinterpretation of the image, such as bubbles of salts appearing as spherical
NP in Figure 3B) and sample damage. But even with coating, the electron beam can still
damage the sample, which could be prevented by low-voltage examination [20]. Although
charging can exert some damage in the TEM as well, this effect presents a problem mainly
in SEM. In the TEM, the largest problem of sample damage by the electron beam is heating,
so a holder cooled with liquid nitrogen (or even helium) is highly recommended [49].
Examples of different structures arising from the EV preparation for EM observation,
which can result in misinterpretations during an EV visualisation, are presented in Figure 3.
The use of phosphate buffer (PBS) as a mobile phase during EV separation by SEC can
form crystals or spherical bubbles of similar size as EVs (Figure 3A,B). In addition, protein
aggregates or lipoproteins [40] of size similar to EVs can be co-isolated in the EV fractions
(Figure 3C,D). They are darker (more electron opaque) and without membranes, but
especially hard to be distinguished from EVs when using conventional EM techniques with
staining and possible collapse of the membrane during the sample preparation.
4.5. Application of EM for Characterisation of EVs from Human Biofluids
In general, SEM analysis plays an important role in determining the morphological
and topographical properties of EVs, which could be correlated with the progress and
the stage of the disease. Standard protocols for preparing EVs for SEM analysis are
usually developed and optimised for EVs isolated in vitro and then applied to the EVs
from the biofluids [64]. Due to the possible cross-interactions and structural changes after
transferring EVs from their original environment to standard SEM preparation protocols,
their native characteristics could be changed. Therefore, optimising the protocol for specific
types and sources of EVs is a critical step towards getting precise information on their
original morphology and its change during a specific disease.
The literature data on the SEM analysis of the EVs from the biofluids are very limited
and only few studies have provided this kind of information (summarised in Table 1).
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A clear example of the effect of the isolation protocol on the EV morphological characteris-
tics is a direct comparison of EVs isolated from the human blood using UC with the EVs
subjected to the affinity column isolation protocol. The EVs, both the ones eluted from the
affinity membrane and the ultracentrifuged pellet, were initially cryofixed by fast freezing
in liquid nitrogen, fixed in GA (2.5 wt% in original elution buffer), dehydrated in acetone
and critical point dried. SEM analysis revealed entities with sizes ranging from 50–200 nm
regardless of the isolation procedure. However, in contrast to UC, for which a significant
number of irregularly shaped objects were detected in the background, affinity separation
was more EV specific and resulted in higher purity. Moreover, the EVs isolated using the
affinity column were more regular, with rounder shape and less fused than those obtained
by the centrifugation protocol [94].
In the case of cancer-sourced EVs, a study included nine patients with castration-
resistance metastatic prostate cancer and twelve healthy volunteers. Cells and EVs were
isolated from their peripheral blood following a centrifugation and immunomagnetic
separation protocol. Then they were fixed in formaldehyde (4 wt%), dehydrated in the
gradual increasing concentration of ethanol and air-dried after a further exchange with
HMDS. Immunomagnetic separation using a ferrofluid conjugated with different antibodies
has proven efficient for cell and EV separation from other similar objects in the complex
blood system. Centrifugation enabled sedimentation of cells with cell-associated and
larger micrometre-sized EVs while smaller, nano-sized EVs could not be identified. They
were suggested to be additionally isolated from the remaining plasma. All circulating
cancer cells were associated with EVs and the majority of them were detected on the cell
surface [95].
EVs were also isolated from the saliva of healthy volunteer donors by a sequential
centrifugation process in PBS [96]. The isolated EVs were deposited on UV-cleaned Si-
wafers, sputtered with iridium and examined using a low–energy beam (1.5 kV). Both
single and aggregated round bulging EVs without a central depression were detected, with
filamentous intervesicular connections observable in their surroundings. These connections
among EVs were assigned to well-preserved extravesicular channels [96].
As already described in the aforementioned examples, SEM mainly detected EVs as
round structures [97] and rarely as cup-structure [98], which is probably due to better
care in the preparation procedures (using critical point drying, gradual dehydration and
exchange with HMDS, which are described in more detail in Section 4.4.3). Nevertheless,
one study attributed the more frequent encountering of collapsed central parts in TEM also
to the additional staining (or sometimes even embedding) steps for enhanced contrast in
TEM, which are not needed for SEM observations [99].
TEM investigations have been conducted on EVs isolated from a variety of human
biofluids (blood, saliva, urine and CSF). Such studies have been generally done at low mag-
nifications, mainly to check the EV isolation procedure and to confirm the size distribution
of EVs and their shape. Thus, TEM analyses clearly revealed that EVs from urine can be suc-
cessfully isolated from the fibril network of the Tamm–Horsfall protein by the addition of
dithiothreitol, which depolymerises the protein disulphide bonds [100], or by dialysis [81].
Sometimes even the concentration of EVs after their isolation from the biofluids was quanti-
fied by TEM, but the results were not reliable due to incomplete and non-uniform adhesion
of EVs to the TEM grid [43,101]. Nevertheless, when Serrano-Pertiera et al. [37] compared
three different isolation procedures (UC, Total Exosome Isolation kit and ExoQuick) for EVs
from blood plasma, TEM images confirmed the higher yield of EV isolation for Invitrogen
kit in comparison with UC. However, with the ExoQuick, precipitates of the kit interfered
with the electron beam, which produced a blurred image, so the authors concluded that the
ExoQuick kit is not suitable for TEM imaging [37]. Kumeda et al. [102] used TEM as one of
the methods for monitoring the stability of the EVs upon storage at different conditions.
Their study revealed that EVs from human saliva can retain their membrane integrity over
a long storage period, even after going through freeze-thaw cycles [102].
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Immunogold labelling was used in a few studies to distinguish the EVs from other
round particles and to get some additional information about their structure [73,80,103–110].
Most commonly, antibodies against the tetraspanin transmembrane protein CD63 were
used, which were employed for immunolabelling of EVs from blood [73,80,103,104,110]
and saliva [107]. Other tetraspanins, such as CD9, have sometimes been targeted instead,
for EVs from the blood [73,80,103] as well as urine [105]. Attachment of such immunogold
NP to EVs indicates their exocytotic origin (they have the cytoplasmic side of the original
membrane inward [105]) and also implies their possible role in signalling distant cells [103].
In relation to western blotting, many other EV-specific epitopes have been selected, such
as the membrane-associated dipeptidyl peptidase IV in EVs from saliva [106] or flotillin-1
in EVs from CSF [109]. Harrington et al. [108] used 9 different antibodies to distinguish
among the different EVs from the CSF that appeared in the TEM images. Cadmium selenide
(CdSe) based quantum dots modified with polyethylene glycol and chemically linked to
interleukin-13 (IL13QD) were prepared with the aim to identify the binding capacity
of IL13QD to EVs from the CSF of the brain tumour patients isolated by differential
centrifugation followed by UC [111]. Quite intriguing is also a recent study on EVs of
seminal origin, in which quantum dots were covalently bonded to the primary amines on
the surface of EVs via click chemistry [112]. This enabled their identification in TEM as
well as a stable fluorescent labelling and live tracking. Rather than specific immunology,
this labelling relies on the common fact that the membranes of EVs are rich in primary
amines. Therefore, additional purification of EVs was required (using SEC after isolation
by UC on sucrose cushion) to prevent labelling of proteins, and the purity of EVs was
checked on the basis of EV-like NP (by NTA) to protein (by bicinchoninic acid assay)
ratio [112]. Immuno-TEM has also been used to trace the origin of the EVs. Thus, a prostate-
specific antigen was targeted to recognise the prostate origin of EVs from plasma [104]
and antibodies against aquaporin-2, podocalyxin and podocin were used to indicate the
renal origin of EVs from urine [105,113]. As evident in Table 1, no notable difference in
the size and morphology of the EVs has been observed in TEM with regards to the type
of biofluid, from which they originated. However, in neither of these conventional TEM
studies were the EVs properly dehydrated before the examination, but merely air-dried
instead. Fixation and UA negative staining have mostly been used, in some cases even the
fixation step was left out [43,78,81,82]. This resulted mostly in the so-called cup-shaped
(or sometimes punched-out ball-shaped) morphology. The same applies also to the STEM
investigations, which have been very rare so far though. By contrast, samples for cryo-TEM
imaging were always prepared according to the required procedure, by plunging them
in liquid ethane, maintained at a very low temperature all the time and observed with
a low electron dose in the TEM. In addition, the great structure preservation during the
cryofixation and absence of drying (dehydration) enabled clear observation of the lipid
membranes. The drawbacks of this method are waste of EVs because of the blotting
procedure, the contrast is poor due to the absence of heavy metals, all the manipulations
must be performed below devitrification temperature and particles larger than 500 nm
cannot be studied [80]. The EVs (particularly the ones below 200 nm [80]) mainly exhibited
perfectly spherical morphology, with a bright (electron-lucent) inside and an evident darker
edge (the membrane). This was true regardless of the chosen biofluid (blood, CSF or semen,
Table 1). They often appeared also as concentric circles with multiple membrane layers
one around another and sometimes as larger vesicles containing one or more smaller ones
inside. Although it has been speculated that such structures emerge during the EV isolation
procedure (such as UC [31] or PROSPR [35], but not SEC [36]). Indeed, Issman et al. [31]
have shown a decrease in the fraction of multi-layered structures upon switching from UC
to filtering or dialysis. They also revealed how slow freezing and thawing of blood plasma
can severely damage the EVs [31]. Moreover, Linares et al. [29] demonstrated irreversible
aggregation of EVs due to UC. Nevertheless, multi-layered circles have been observed
even indirectly in cryofixed biofluids without any EV isolation [79,114]. Sometimes the
spherical EVs are additionally decorated with small (6 nm) spherical NP (most probably
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proteins) residing around 5 nm away from the surface of the EVs, which gives the so-
called cauliflower-like morphology [77,79]. In a few studies, electron-dense nanospheres
of similar size to the electron transparent circles were observed. These darker structures
without visible membrane were ascribed to lipoproteins [32,79]. In fact, they represented
the majority of the NP in a biofluid (only around 1% of them in plasma [79] and 10% in
semen [114] were EVs). Recently, exomeres a sub-50 nm particles have been discovered,
also a non-membranous structures [1,10].
Table 1. Morphological and structural characteristics of the EVs from the human biofluids as obtained by electron microscopy.
Method Biofluid Shape Structure/morpHology/Topography Size (nm) References
SEM
blood regular vs. Irregularspherical
aggregated, rough surface,
adhered to cell surface, rough surface,
non-fused vs. fused
/ [94,95]
saliva round—irregular individual and aggregated,rough surface / [96]







cytoplasmic side inward 30–240 [37,43,80,103,104,110,116–118]
saliva round
individual vesicles














/ 20 to >20020–150
[14,43,108,109,111,
120–122]








apparent lipid membrane, actin
filaments visible, granulated, smooth,
bilayered, multilayered, with smaller










trilamellar membrane, 5 nm
cauliflower-like protrusions 4 nm
away from the 5 nm thick membrane,
most double or triple, a few single
vesicles, vesicle sacs containing 6 or
more EVs, pleomorphic membrane
structures, coated membranes,







single, double, multi-layered, clear
presence of lipid bilayer/membrane 26–435 [32,78]
Elongated oval and tubular particles could also be observed occasionally as well as
odd-shaped particles or particles with membranes damaged during the isolation, purifica-
tion and cryo-TEM preparation procedure [29,32,35,79,114]. Hence, there is a large variety
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of EV morphologies in every biofluid. 11 subcategories and 88 different types have been
reported for human semen [114], whereas around 10 different types have been displayed
in blood plasma [79] and about the same number for CSF [32]. With all these different
structures it was logical to apply immunogold labelling in cryo-TEM studies as well [29,35].
Gallart-Palau et al. [35] relied on the membrane-associated CD9 and ALIX (adaptor protein
for endosomal sorting complex required for transport) proteins as the epitopes, respectively,
and 10 nm colloidal Au NP labelled secondary antibody to bind to them. They bound to
the single-layered as well as multi-layered EVs from blood plasma [35]. A very interesting
approach with double immunogold labelling can be seen in the work by Linares et al. [29],
in which they used gold NP of two different sizes and functionalisations: 10 nm Au NP
with antibody against integrin CD41 (or glycophorin-A CD235a) and 4 nm Au NP conju-
gated with Annexin A5. Double labelling on a single EV implies fusion between EVs of
different cell origin or transfer of membrane-bound antigens between EVs [29].
Despite the possibility to directly analyse morphology and structure of EVs, EM
techniques are generally considered as too localized, they take information from a small,
usually statistically non-relevant size of the sample and are hardly reproducible [123].
However, in combination with other methods and strictly following optimised preparation
protocols it can provide more reliable results and enable valuable information for study
EVs complex role in intercellular communication and pathogenesis.
5. Atomic Force Microscopy
AFM is a nanoscale tool for the determination of morphology, structure and composi-
tion, but also biomechanics and biophysical characteristics of nanometric structures [45,47].
Briefly, AFM uses a micrometric cantilever with a nanometre-sized tip actuated by piezo-
electric crystals. Upon receiving signals of a tip-sample interaction, a position-sensitive
photodiode (PSPD) converts it to a voltage and sends it to a piezoelectric actuator (PA).
The latter expands and contracts proportionally to the applied voltage to manipulate the
sample and the probe position across three dimensions with high precision. The PA can
be coupled to a cantilever [124] or positioned under a sample holder (Figure 4(aA)). The
whole system is controlled by suitable control electronics.
The laser beam is pointed on top of the cantilever and reflects onto the PSPD. When the
tip passes over a topology feature, the laser beam reflects the cantilever’s motion and creates
voltage signals on a PSPD. The received signal from the PSPD contains information about
the cantilever’s motion which the computer tracks in x-y-z directions for the reconstruction
of a topographical image [125]. The tip’s height above the surface is controlled by a
feedback loop. To keep the interaction forces between the tip and the surface constant, the
feedback system uses the PA to fine-tune the interaction motion in the z-axis direction. The
position of the reflected laser beam is influenced by the exerted force and other interactions
of the cantilever with the surface, but also by the frequency and amplitude of the tip’s
oscillations and their combinations. Thus, besides the topography of the observed surface,
its mechanical properties, e.g., stiffness, adhesion, and elasticity, can be obtained based on
the measurements of interaction forces between the micro-cantilever tip and the surface of
the sample at the micro- and nano-scale level.
5.1. Modes
A crucial parameter for successful imaging is the selection of the appropriate mode
of operation. AFM operates in several modes: contact, tapping (or intermittent contact),
non-contact and PeakForce TappingTM (Bruker, Billerica, MA, USA). The results obtained
from the different modes are images or force curves [45]. When the surface of the sample is
scanned, its topology is recorded from the generated signals on the PSPD (Figures 4b and 5).
These images can be collected in the contact mode when the tip is in continuous contact
with the surface while moving in raster scan lines over a predefined scan size. The force
value remains constant since the distance of the cantilever from the surface of the sample is
modified for each variation of the surface height via feedback control of the PA. It provides
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the fastest measurements in comparison with other modes. Yet, the continuously imposed
friction can damage the sample due to high lateral forces. For this reason, it is important
to optimise the interaction between the tip and the sample to minimise the damage and
deformation of soft, biological samples. Therefore, tapping and PeakForce Tapping modes
are usually applied where more precise force control with respect to contact mode and
non-contact mode is achieved.
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photodiode, PA: piezoelectric actuator, S: sample. Representative images of EVs in air (D) and liquid (E). (D): sample fixed
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II (JPK Instruments) with MLCT (Bruker) probes in tapping mode, with photothermal excitation, EV-like structures are
pointed with white arrows.
In the tapping mode (TM) the tip oscillates across the sample surface modulated
according to the sample’s height. At the lowest position of oscillation, it briefly touches the
sample, thus protecting the sample from damage. The feedback loop keeps the vibration
amplitude constant, and the applied force (2–10 nN) is controlled by the ratio between the
amplitude setpoint and the amplitude of free oscillation. Tapping mode AFM can detect
the biochemical and mechanical characteristics of the sample, its density and viscosity.
The changes in the amplitude and phase of the cantilever oscillations with respect to the
excitation signal can be recorded simultaneously with the topographic height.
In the PeakForce Tapping (PFT) mode the tip is used as a few pN force probe controlled
by a low driving frequency and amplitude. In addition to lateral movement, the tip is forced
to oscillate in the vertical direction. Unlike in TM, the piezo oscillates far below (1–2 kHz)
the resonance frequency in z-axis direction. The maximum loading force (called peak
force) perpendicular to the surface (indentation) is controlled and the computer tracking is
optimised according to the peak force setpoint and the gains. The applied force is below the
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usually achievable values in TM [96,126,127]. It should be controlled very well for imaging
of EVs, as it was observed that the shape of EV changes with the increase of the applied
force [96]. While detecting the deflection of the cantilever, indentation curves or unfolding
curves of a protein are collected [125]. The detected changes in the oscillation (amplitude,
phase, or frequency) are used in feedback to maintain a constant interaction of the probe
with the sample. The image is generated by capturing the force/distance curve on each
image pixel [127,128]. The PFT mode, besides the topography, gives information about
the biomechanical, biomolecular and biophysical characteristics of NP based on the force
curves. The adhesion force, elastic modulus, deformation and dissipation are used for the
calculation of quantitative nanomechanical information: adhesion forces, elasticity, stiffness,
and deformation. EVs are exposed to different forces when attached to surfaces, during
intercellular and extracellular transport, or internalisation and externalisation by cells. The
measurements of biomechanical properties, the so-called mechanical fingerprint, can help
elucidate these processes without the use of biochemical markers, and also give insight into
adhesion-related diseases. Rigidity is one of the important properties that can distinguish
different classes of EVs [47,96,129]. The central part of some EVs is softer compared to
the rigid membrane and consequently a collapsed cup is formed. This can be avoided by
working in very soft amplitude modulation conditions or PFT mode [130]. The membrane
rigidity of EVs is generally determined by their size, lipid and protein composition, and
the attractive forces on the substrate [126]. Mechanically, most EVs behave like empty
liposomes with a fluid bilayer containing significant amounts of membrane-associated
proteins [127].
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PeakForce QNMTM (Bruker) is an additional mode that visualises the height and the
Quantitative Nano Mechanical (QNM) properties of the sample simultaneously. The first
part is the PFT mode used as the feedback mode to track and image the sample surface.
The QNM part uses PeakForce Tapping mode to produce force curves, from which the
quantitative data on the material properties are extracted.
In non-contact mode, the cantilever oscillates at the constant distance in the close
proximity above the sample, without touching its surface. As the distance is kept constant,
the interaction forces between the tip and sample are in the piconewton (10–12 pN) order
of magnitude (very low). By measuring either the changes in the resonant frequency or the
changes in the amplitude the final image is obtained. Even though the contact forces are
minimized, and the tip and the sample are preserved from the damage, the downsides of
this mode are its slower scanning speed and the requirement for an ultra-high vacuum to
achieve the best performance (to prevent any liquid adsorption to the tip).
There are several programs available for the postprocessing of AFM images. In
particular, Skliar and Chernyshev [46] presented steps in Gwiddyion (Czech Metrology
Institute, Brno, Czech Republic) for data analysis of the images of EVs. Besides the height,
different parameters and characteristics, e.g., topography, morphology or root-mean-square
roughness, can also be extracted.
5.2. Environments
Unlike EM that operates only in a vacuum and thus affects the surface morphology,
AFM can operate at normal conditions and in two environments: air (Figure 4(aB),(bD)) or
liquid (Figure 4(aC),(bE)) [124,126,128,130]. The air environment implies drying a sample
in a gentle nitrogen stream, and it has been shown that the EVs analysed in air shrink
and develop a characteristic cup shape during this evaporation process due to the central
softer area collapsing with respect to the surrounding parts [84], explained in Section 4.4.3.
Conversely, the liquid environment could better reflect the physiological environments in
which EVs reside, under physiological conditions (i.e., in a buffer solution) and without the
need for coating or any other modifications of the sample [128,131]. This better preserves
the spherical shape of the EVs, but it is more complicated for the optimisation of the laser’s
position and noise reduction. Hence, the imaging in the air is useful when checking the
presence of vesicles and the quality of the sample. However, imaging in liquid is the
optimal choice since it preserves EVs properties and reflects their natural state [125,128]. In
Figure 5, different round and cup-shaped NPs in a native cerebrospinal fluid are imaged
by the AFM in the air (A) and liquid (C) environments and the corresponding images of
EVs after their isolation by SEC are displayed in the air (B) and liquid (D) environments. It
is challenging to determine the exclusive influence of the environments on the shape of the
NPs, it is rather a complex mixture of factors like different forces, the substrate applied for
attaching the sample and the sample preparation protocols.
5.3. Cantilevers and Drives
Generally, each imaging mode will require different cantilevers depending on the mea-
surement mode and whether the imaging is performed in liquid or in air (Figure 4(aB),(aC)).
Usually, the laser power can be tuned to accommodate various drive requirements for
operation in air or liquid. The cantilevers are normally mechanically driven by feeding an
AC signal to a piezo transducer, but there exists a possibility for a photothermal excitation
(Figure 4(bE) and Figure 5(bD)). This setting enables, in addition to the usual deflection
laser beam that focuses onto the cantilever, a second blue laser used for the excitation of
the cantilever to trigger its vibration. This is particularly useful for AFM imaging in a
liquid. The response of the cantilever using the PA is mechanically driven by the reso-
nances of the AFM. Thus, in the liquid environment, problems arise due to noise formation.
However, with photothermal excitation, only the cantilever is excited without influencing
other mechanical components in the AFM, and thus a clean response is produced, even in
liquids. This method was implemented on the CypherTM family of Asylum Research AFMs
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(Oxford Instruments, Santa Barbara, CA, USA) and named blueDriveTM photothermal
excitation [132].
The resolution of the AFM depends on the size of the probe that is used to scan the
surface of interest. To follow nanometric features, tips with an apex with a nanometre-sized
radius of curvature are essential [125]. Also, due to the tip convolution, the particles (and
other nanometric features) appear wider than they are in reality, which occurs especially
when particles are of similar or smaller radii than the tip. To account for this deformation
from the AFM tip in TM, deconvolution methods must be applied to calculate the actual
size of the EVs, even at low forces [47]. Sebaihi et al. [133] found that for the erythrocyte-
derived EVs the convolution tip effect was about 19% on the lateral measurement. The
recommendation is to select tip probes of around 1 nm size for the measurements of EVs.
EVs are extremely soft, so cantilevers from silicon or silicon nitride are mainly
used [127]. Low forces should be applied (the force depends on the spring constant
of the cantilever), such that the EVs are minimally perturbed. Also, short interaction
between the sample and the tip should be used to reduce the drift of the sample or the cup
shape formation. It has been shown that an EV flattens as the force increases above 2 nN
and ruptures after 5 nN [47,96]. In the case of most commonly used TM, softer cantilevers
with a spring constant value lower than 0.5 Nm−1 are employed. For PFT cantilevers with
resonant frequencies ranging between 66 and 89 kHz, spring constants ranging between
1.4 and 3.5 Nm−1 at a rate of 0.1–1 Hz have been used for EVs imaging [44,48,107,130,133].
AFM tip is applied also for single protein [134] and single EV investigations [96].
The single EV resolution is obtained by an antibody-coated tip and the forces perpen-
dicular to the surface of the sample are measured as a result of the protein-antibody
interactions [20,135].
5.4. Sample Preparation
Generally for imaging, the sample is applied onto a different flat substrate with surface
roughness under 0.5 nm, which enables distinguishing the EVs from the imperfections
of the surface or impurities [130]. Before attachment onto the substrate, EVs should be
fixed with aldehydes (2–4% of PFA–paraformaldehyde or GA) that stabilise the nucleic
acid-protein interactions and free amino groups by a cross-linking effect, which preserves
the EV structure, as previously discussed in the Section 4.4.2. The materials frequently
used as substrates for AFM applications are mica, glass coverslip, Si-wafer and stainless
steel, or other metals. EVs are deposited on: (i) free surface, (ii) functionalised surface with
a coating that binds unspecifically and (iii) antibody-coated surface for specific binding.
Consequently, the EVs are adhered because of physical adsorption, electrostatic interactions,
chemical bonds or hydrophobic interactions [47,126].
The mica that is freshly exfoliated to obtain a new flat layer has a residual negative
charge, which makes the electrostatic interaction between the surface and the EVs sufficient
to keep them attached to the surface. This applies to the imaging in the air when a washing
procedure and drying under a nitrogen stream are performed. For imaging in a liquid
environment, the attachment time should be prolonged, though [130].
For application on a glass coverslip, Si-wafer, stainless steel or other metals it is neces-
sary to clean the surface of the substrate (e.g., by applying the so-called RCA standard clean,
developed by Werner Kern in 1965 while working for Radio Corporation of America) [136]
and create a residual charge on it, and also to enhance the binding of EVs for the substrate,
e.g., by applying oxygen plasma treatment. There are also several non-specific coating
solutions used for the same purpose: NiCl2, poly-L-lysine, GA, amine groups, peptides or
aptamers [45,46,128,137,138].
EVs are negatively charged, so they bind strongly to the positively charged surfaces,
such as poly-L-lysine, but not well to the negatively charged surfaces, such as unmodified
mica. However, the strong adhesion of an EV to a positively charged substrate causes its
structural deformation in height leading to a flattened/flat and oblate shape, so that the
height/diameter ratio is much less than 1. By contrast, EVs adsorbed to mica exhibit more
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or less roundly shaped morphology, even though, depending on the force applied with
AFM tip, it is possible that some EVs, based on their intrinsic properties (stiffness, internal
structure), also exhibit some irregular morphologies, including convex, planar or concave
(cup-shaped). Nevertheless, the stiffer EVs remain almost completely spherical [139].
The glass is generally selected if good optical properties are required, such as for the
combined study of AFM imaging and light microscopy [130], microchip platform investiga-
tions [140], or the platform for single EV measurements combining fluorescence microscopy
and AFM [138]. Gajos et al. [141] used silicon wafers with native oxidized silicon layers
(SiOx) for attaching EVs generated from activated platelets and human platelet-poor plasma
while Beekman et al. [44] used oxygen-treated stainless steel for multimodal analysis. There
are some other examples like utilisation of 3-aminopropyltrietoxysilane (APTES), for ob-
taining smooth surface (named as AP-mica), also aminopropyl silatrane (APS) to yield an
APS-mica surface [142] or 3-aminopropyltrimethoxysilane (APTMS) [127]. Ito et al. [126]
used as-cleaned SiO2/Si, (APTES)-modified SiO2/Si, and as-cleaned TiO2 (as-cleaned refers
to ultrasonically cleaned, placed consecutively in acetone, methanol, de-ionized water and
dried in nitrogen) for attaching EVs from different cancer cell lines.
There are also different antibodies specifically used for functionalisation/coating
of the surface, namely targeting membrane proteins that will capture EVs with specific
epitope. The application of the antibody-coating to the surface is challenging and should
include controls of the surface roughness and the presence of impurities. Hardij et al. [128]
applied ethanolamine and glutaraldehyde to attach the antibody onto the substrate. Func-
tionalisation of the surface is necessary in cases when EVs need to withstand the imaging
forces (e.g., PFT), but has its pros and cons. A strong affinity of a soft vesicle for the surface
can cause irreversible deformation while a weak affinity of a stiff vesicle may not be enough
to retain EVs on the surface. As a result, only the specific subpopulation is imaged.
There are several antibodies applied for EVs capture. Gandham et al. [1] coated mica
surface with anti-CD41 for attaching platelet-derived EVs and Sebaihi et al. [133] used
anti-CD235a-modified mica for erythrocyte-derived EVs. Anti-CD142 coated mica was
used to capture EVs derived from MDA-MB-231 cell line [128], anti-CD41 coated mica for
EVs from platelet-poor plasma [143], anti-PAC-1-coated silicon for platelet-derived mi-
crovesicles [141]. Beekman et al. [44] used anti-EpCAM (epithelial cell adhesion molecules)
to target tumour-derived EVs on stainless steel substrates previously functionalised with a
monolayer of carboxydecyl phosphonic acid (CDPA) and investigated them by different
methods, including SEM, AFM and Raman.
5.5. Aplication of AFM in Characterization of EVs from Human Biofluids
The application of AFM to investigate EVs from biofluids is still scarce. Most research
has been performed on cell lines in vitro with UC as the method for isolation of EVs due to
the high volume of supernatant. Recent studies point to some other methods for isolation
previously discussed in the Introduction. However, discrimination of EVs from all NPs
in highly complex samples like blood or plasma is challenging. EVs are outnumbered by
non-EV particles (liposomes and globular proteins) that are in the same size range, which
obscures and impedes the analysis of EVs. In recent years, the application of microscopy
for characterisation of structure, morphology, size distribution, density, mechanical and
biophysical properties of EVs, as well as their structural organisation in biofluids has
advanced considerably. AFM is used for investigations of EVs in various biofluids, such
as saliva, blood, plasma and serum, cerebrospinal fluid and others summarised in Table 2.
Different terminology is used for describing different shapes or some morphology aspects,
e.g., spherical, hemispherical, cup, ellipsoidal and flat, which creates ambiguity. It is
difficult to perform a downstream analysis when these factors are not thoroughly evaluated
on a single EV level [127].
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Table 2. Morphological and structural characteristics of the EVs from the human biofluids as obtained by atomic force
microscopy.
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The most investigated is saliva because of its availability. AFM was applied for the
investigation of 2D and 3D topographic images and molecular features of EVs [107]. Pooled
samples of saliva from healthy individuals were isolated by two methods: ExoQuick and
UC. TM AFM imaging in air conditions revealed larger (>100 nm), heterogeneous, irregu-
larly shaped, aggregated EVs after isolation by ExoQuick, in contrast to the homogeneous,
single, round-shaped EVs that were isolated by UC. The structure and biomechanical prop-
erties were investigated for UC isolated saliva exosomes from healthy individuals at the
single vesicle level [96]. TM height images in air conditions with forces below 1 nN revealed
round 50–70 nm EVs. The amplitude images with applied forces around 2 nN showed EVs
with similar morphology, an average diameter around 100 nm and an indent in the centre
pointing to mechanical deformation by the tip. The phase images with 2 nN forces also
revealed a 3D trilobed structure and substructures in the centre of the EVs with different
contrast (possible from different constituents, namely lipids, proteins, nucleic acids). If high
forces were applied, structural deformation and disintegration followed. The importance
of the implementation of immuno-based detection methods lies in distinguishing EVs from
other structures like globular proteins. It involves functionalisation of the flat surface that
EVs are attached to or tip functionalisation. Sharma et al. [96] detected a single-molecule of
transmembrane protein CD63 on the surface of saliva EVs imaged under PBS in TM via
targeted force spectroscopy with an antibody-coated tip and antibody-labelled gold beads.
This principle enables the detection of specific membrane markers for specific diseases (e.g.,
oral cancer) on the membrane of EVs from biofluids after mass spectrometry detection of
the target protein in subpopulations of EVs. Topographic images have been applied to
compare the UC-isolated exosomes from the saliva of healthy individuals with the saliva of
oral cancer patients [144]. Using TM AFM in the air, the normal exosomes exhibited circular,
homogeneous, bulging structure and diameter of 40–80 nm, with a distinct phase contrast
between the less dense vesicle periphery and the more dense core region. On the other
hand, cancer exosomes were bigger with broader distribution of 20–400 nm and manifested
irregular morphologies, aggregation and clustering. Also, the larger EVs appeared hollow
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without the dense core region seen in the normal EVs. Furthermore, cancer exosomes
indicated a possible increased surface CD63 density [144].
Urinary EVs have been found to own great potential applications in disease diagnosis,
therapy and disease molecular mechanism. The urine is rich in Tamm-Horsfall protein
(around 92 kDa) and other biological components. Yang et al. [81] isolated EVs by dialysing
urine in 300 kDa dialysis tubes in PBS solution, and then the dialysis suspension was
concentrated by using 100 kDa ultracentrifuge tubes. Samples were analysed by AFM
in TM on freshly cleaved mica in air conditions and showed a round structure with no
aggregation or disruption.
The erythrocyte-derived EVs, isolated by UC were imaged by TM AFM on anti-
CD235a-modified mica [133]. Glycophorin A (CD235a), uniquely expressed on the erythro-
cyte membrane was chemically attached to mica. EVs examined under buffer in liquid and
in air conditions showed similar morphology in both media, spheroidal shape, around
30 nm high and 90 nm wide. Rikkert et al. [145] investigated blood-derived EVs on a poly-L-
lysine coverslip by AFM in PBS environment with PFT mode using minimal imaging force.
Their topography and mechanical properties were obtained from the force-indentation
curves. The particles were 25 nm high with a spherical shape. The authors pointed out that
AFM imaging alone is not enough for distinguishing between EVs and lipoproteins. There-
fore, an isolation protocol combining gradient- and size-based approaches is necessary to
ensure the presence of only EVs [145]. Blood samples of 96 patients were investigated for
the monitoring of fingerprint for CNS tumours (glioblastoma multiforme, benign menin-
gioma and single brain metastasis originating from non-small-cell lung cancer) carried by
small EVs [146]. EVs were isolated by UC and the presence of small EVs was confirmed
by AFM in TM, in PBS solution. Their size range spanned from 50 to 140 nm and they
appeared as various structures. The force spectroscopy measurements of EVs are still
scarcely studied. Bairamukov et al. [139] found a correlation between the biomechanical
properties of the EVs, their size, structure, and function. They used PeakForce QNM in
air and liquid for measurements of exosomes and exomeres isolated by UC from blood
plasma. This AFM mode, as mentioned earlier, acquires high-resolution (HR) AFM im-
ages with force spectroscopy measurements at the same time. The measurements of the
biomechanical properties revealed a soft internal cavity that was referred to as a disk-like
shape, a stiffer membrane for exosome in the liquid and near-spherical shape in the air.
By contrast, exomeres had similar heights in the air and the liquid environments [139].
EVs are considered promising biomarkers for thrombotic risk. AFM imaging of EVs from
platelet-free plasma on tissue factor (TF) coated mica revealed only a few vesicles, with a
size range of 60–100 nm [128]. Biomechanical investigations are important for the detection
of a difference between normal and cancerous EVs. Vorselen et al. [127] compared EVs from
healthy individuals with the ones from the patients with hereditary spherocytosis (HS) by
measuring their biomechanical properties in PFT mode, in PBS. Blood-derived EVs, which
were isolated by UC and adhered to poly-L-lysine on APTMS coated glass slides, appeared
as spherical structures with a mean radius of 71 nm. Furthermore, HS patient-derived EVs
were significantly softened in comparison with the healthy donor-derived EVs, and their
protein composition was altered.
The first-ever 3D images of NP in native CSF are presented in Figure 5(aA), on mica
in the air (A) and in the liquid (C), showing two distinct structures: round and cup shape.
These structures can also be visible in Figure 5(aB), representing SEC-isolated EVs on
mica in the air (C) with possible convolution artefacts or PBS crystals (used as mobile
phase during EV separation by SEC) and on a glass coverslip in the liquid, RCA cleaned
and activated with oxygen plasma (D). Similar features are visible for the EVs isolated
by SEC in Figure 4(bD),(bE) too. For exploring the impact of different parameters on
the shape and morphology of EVs, additional effort should be invested in assessing the
influence of the single factors, e.g., isolation method, or settings in the AFM imaging, prior
to downstream analysis.
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6. Conclusions
AFM and EM methods are powerful tools to characterise EV morphology. However,
both the EV and microscopy-associated aspects can significantly affect the final imaging
results and thus require detailed and dedicated optimisation. On one hand there is the
milieu containing the EVs to be visualised. The milieu can be either a biofluid or a
buffer after EV isolation. Each type of EV-containing milieu can have specific acidity,
salt composition and concentration, all of which can significantly influence downstream
procedure of sample preparation for microscopy techniques. On the other hand, AFM and
EM sample preparation protocols and methods are equally possible in myriad versions
and are not standardised, thus they render the microscopic characterisation of EVs variable
and unreliable. Several factors cause this variability and different terminology is used
for describing the variation in the shape, morphology, structure and topography of EVs.
Special attention should be focused on the steps in the sample preparation protocols and on
controlling the formation of artefacts. Along with the standard application of EM and AFM
for revealing the presence of EV-like structures and impurities, a single-EV approach based
on immuno-detection should be introduced to reduce the level of uncertainty. The sources
of variation should be evaluated before any downstream analyses so that misinterpretations
during the investigations of the biological functions of EVs can be prevented.
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